Stomach Cancer Market Growth Forecast With Analysis Of Industry Progress Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Increase In Market Value Is Predicted For The Stomach Cancer Market During The 2026–2030 Period?

The stomach cancer market has experienced rapid expansion recently. This market is projected to expand from $3.74 billion in 2025 to $4.26 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.9%. Factors contributing to its growth during the historic period include the escalating incidence of gastric cancer globally, the widespread presence of helicobacter pylori infections, the greater adoption of chemotherapy as a standard treatment, the expansion of hospital oncology infrastructure, and advancements in diagnostic imaging techniques.

The stomach cancer market size is projected to experience significant growth in the coming years. It is anticipated to reach $7.14 billion by 2030, with a compound annual growth rate (CAGR) of 13.8%. The expansion during the forecast period can be attributed to the rising adoption of precision oncology, increased investment in novel biologics, the broadening of immunotherapy pipelines, a greater focus on detecting cancer in its early stages, and improved access to advanced cancer treatments. Key trends in the forecast period involve the increasing embrace of targeted therapy regimens, a rising application of immunotherapy combinations, a growing emphasis on early diagnostic screening, the expansion of personalized treatment strategies, and enhanced integration of biomarker-based testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25913&type=smp

What Important Drivers Are Powering The Stomach Cancer Market Growth?

The increasing occurrence of Helicobacter pylori infection is anticipated to boost the expansion of the stomach cancer market moving ahead. Helicobacter pylori infection describes a state brought about by the Helicobacter pylori bacteria, which inhabits the stomach’s inner lining, potentially resulting in inflammation, sores, and an elevated likelihood of stomach cancer. The growing incidence of Helicobacter pylori infection is largely attributable to inadequate hygiene, promoting the spread of the bacteria through fecal-oral and oral-oral routes in crowded or unsanitary environments. Helicobacter pylori infection contributes to stomach cancer by inducing long-term inflammation and cell harm within the stomach lining, fostering precancerous alterations and the formation of tumors. As an illustration, in November 2024, data from the Government of Canada, a Canada-based government agency, indicated that the Helicobacter pylori infection recurrence rate reached 19% in 2023, with this rate fluctuating depending on geographical area and age demographic. Consequently, the increasing occurrence of Helicobacter pylori infection is propelling the expansion of the stomach cancer market.

How Are Different Segment Groups Identified Within The Stomach Cancer Market?

The stomach cancer market covered in this report is segmented –

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Therapy Type: Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Ambulatory Surgery Centers, Hospitals And Specialty Clinics, Other End-Users

Subsegments:

1) By Adenocarcinoma: Intestinal Type, Diffuse Type

2) By Lymphoma: Mucosa-Associated Lymphoid Tissue Lymphoma, Diffuse Large B-Cell Lymphoma

3) By Gastrointestinal Stromal Tumor: Kit-Positive Gastrointestinal Stromal Tumor, Platelet-Derived Growth Factor Receptor Alpha-mutant Gastrointestinal Stromal, Wild-Type Gastrointestinal Stromal Tumors

4) By Carcinoid Tumor: Typical Carcinoid, Atypical Carcinoid

5) By Other Types: Squamous Cell Carcinoma, Small Cell Carcinoma, Undifferentiated Tumors

Which Trends Are Expected To Shape The Stomach Cancer Market?

Prominent companies operating in the stoma or ostomy care market are concentrating on technological breakthroughs, such as customizable convexity design, to offer superior solutions to ostomy patients that ensure a secure attachment, prevent leakage, and heighten comfort for varying body types and stoma configurations. Customizable convexity design signifies the capacity to modify the tension’s placement and the convex depth within ostomy barriers, enabling a bespoke fit that enhances stoma protrusion, skin flattening, and overall comfort for different body structures. For instance, in April 2024, Convatec Group, a UK-based medical device company, introduced Esteem Body with Leak Defense in the U.S., a one-piece soft convexity ostomy system. Developed for various body types and stoma shapes, it integrates advanced adhesives, offers multiple convexity options, and features a patented ‘8-shape’ pouch for increased comfort, security, and leak prevention.

Which Firms Are Competing In The Stomach Cancer Market?

Major companies operating in the stomach cancer market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck And Co. Inc., Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Amgen Inc, Daiichi Sankyo Company Limited, BeiGene Ltd., Celltrion Healthcare Co. Ltd., Biocon Limited, Zai Lab Limited, MacroGenics Inc., Astellas Pharma Inc., Ipsen Group, AbbVie Inc., Bayer AG, Ono Pharmaceutical Co. Ltd.

Access The Complete Stomach Cancer Market Report:

https://www.thebusinessresearchcompany.com/report/stomach-cancer-global-market-report

Which Region Accounts For The Highest Share Of The Stomach Cancer Market?

North America was the largest region in the stomach cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stomach cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Stomach Cancer Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25913&type=smp

Browse Through More Reports Similar to the Global Stomach Cancer Market 2026, By The Business Research Company

Esophageal Cancer Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Gastric Cancer Diagnostic Procedure Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Tumor Ablation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795